These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27457489)

  • 1. A case of acquired haemophilia A complicated by peritonitis after distal gastrectomy.
    Sato K; Tsukada N; Inamura J; Kon M; Ito S; Hirai K; Hosoki T
    Haemophilia; 2016 Sep; 22(5):e469-71. PubMed ID: 27457489
    [No Abstract]   [Full Text] [Related]  

  • 2. Acquired haemophilia in a patient with Castleman's disease: a case report.
    Katsuyama T; Sada KE; Katayama A; Hinamoto N; Wakabayashi H; Kawabata T; Makino H
    Haemophilia; 2012 Jul; 18(4):e360-2. PubMed ID: 22630343
    [No Abstract]   [Full Text] [Related]  

  • 3. Acquired haemophilia A: a case report.
    Colomba D; Di Raimondo D; Marino L; Marrone R; Licata G
    Intern Emerg Med; 2010 Apr; 5(2):169-71. PubMed ID: 19784752
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.
    Hay CR; Negrier C; Ludlam CA
    Thromb Haemost; 1997 Dec; 78(6):1463-7. PubMed ID: 9423795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune haemophilia in a teenager.
    Batra S; Sharathkumar A; Glaubach T; Gamerman S; Green D
    Haemophilia; 2013 Nov; 19(6):e386-8. PubMed ID: 23992250
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa.
    Xu Y; Zhang X; Zhao Y; Zhao L; Qiu H; Wu D
    Haemophilia; 2013 Mar; 19(2):e95-6. PubMed ID: 23231056
    [No Abstract]   [Full Text] [Related]  

  • 7. Major orthopaedic surgery for a haemophilia patient with inhibitors using a new bypassing agent.
    Takedani H; Hirose J; Minamoto F; Kubota M; Kinkawa J; Noguchi M
    Haemophilia; 2016 Sep; 22(5):e459-61. PubMed ID: 27456673
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
    Kubisz P; Plamenová I; Stasko J; Dobrotová M; Hollý P
    Thromb Haemost; 2010 Apr; 103(4):868-70. PubMed ID: 20135075
    [No Abstract]   [Full Text] [Related]  

  • 9. Acquired haemophilia: dynamic whole blood coagulation utilized to guide haemostatic therapy.
    Johansen RF; Sørensen B; Ingerslev J
    Haemophilia; 2006 Mar; 12(2):190-7. PubMed ID: 16476097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain.
    Jimenez-Yuste V; Núñez R; Romero JA; Montoro B; Espinós B
    Haemophilia; 2013 Nov; 19(6):841-6. PubMed ID: 23758100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitor development in two cousins receiving full-length factor VIII (FVIII) and FVIII-Fc fusion protein.
    Ragni MV; Alabek M; Malec LM
    Haemophilia; 2016 Sep; 22(5):e462-4. PubMed ID: 27501368
    [No Abstract]   [Full Text] [Related]  

  • 12. International survey of attitudes towards secondary prophylaxis with recombinant factor VIIa in haemophilia A patients with inhibitors.
    Mannucci PM; Palhares de Miranda PA
    Haemophilia; 2009 Jan; 15(1):345-7. PubMed ID: 19149858
    [No Abstract]   [Full Text] [Related]  

  • 13. New advances in the therapeutic and laboratory management of patients with haemophilia and inhibitors.
    Dargaud Y; Lambert T; Trossaert M
    Haemophilia; 2008 Jul; 14 Suppl 4():20-7. PubMed ID: 18494689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
    Blatny J; Kohlerova S; Zapletal O; Fiamoli V; Penka M; Smith O
    Haemophilia; 2008 Sep; 14(5):1140-2. PubMed ID: 18540894
    [No Abstract]   [Full Text] [Related]  

  • 15. Promising coagulation factor VIII bypassing strategies for patients with haemophilia A.
    Duan X; Tang M; Zhang J; Yu H; Xu R
    Blood Coagul Fibrinolysis; 2014 Sep; 25(6):539-52. PubMed ID: 24614429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excision of pseudotumour in a patient with haemophilia A and inhibitor managed with recombinant factor VIIa.
    Takedani H; Mikami S; Kawasaki N; Abe Y; Arai M; Naka H; Yoshioka A
    Haemophilia; 2004 Mar; 10(2):179-82. PubMed ID: 14962208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery.
    Doughty HA; Northeast A; Sklair L; Roques T; Young AE; Savidge GF; Hunt BJ
    Blood Coagul Fibrinolysis; 1995 Apr; 6(2):125-8. PubMed ID: 7605877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acquired hemophilia in the elderly. Study of 10 cases.
    Rodríguez-García JA; Martínez-Robles V; Pérez-Gutiérrez B
    Med Clin (Barc); 2019 Jan; 152(1):34-36. PubMed ID: 29685311
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of fulminant postoperative bleeding due to acquired haemophilia.
    Mekenkamp LJ; Beishuizen A; Slomp J; Legdeur MC; Klaase JM; Trof RJ
    Neth J Med; 2015 May; 73(4):182-6. PubMed ID: 25968291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia.
    Dehmel H; Werwitzke S; Trummer A; Ganser A; Tiede A
    Haemophilia; 2008 Jul; 14(4):736-42. PubMed ID: 18445011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.